UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 318

Sortiert nach

Bortezomib for the treatment of multiple myeloma

Cochrane database of systematic reviews, 2016-04, Vol.4 (4), p.CD010816-CD010816

2016

Link zum Volltext

Verfügbarkeit prüfen

Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials

Blood, 2010-07, Vol.116 (3), p.354-365

2010

Link zum Volltext

Verfügbarkeit prüfen

Minimal residual disease monitoring by quantitative RT-PCR in core binding factor AML allows risk stratification and predicts relapse: results of the United Kingdom MRC AML-15 trial

Blood, 2012-10, Vol.120 (14), p.2826-2835

2012

Link zum Volltext

Verfügbarkeit prüfen

Optimization of Chemotherapy for Younger Patients With Acute Myeloid Leukemia: Results of the Medical Research Council AML15 Trial

Journal of clinical oncology, 2013-09, Vol.31 (27), p.3360-3368

2013

Link zum Volltext

Verfügbarkeit prüfen

Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trial

Lancet neurology, 2010-06, Vol.9 (6), p.581-591

2010

Link zum Volltext

Verfügbarkeit prüfen

Addition of Gemtuzumab Ozogamicin to Induction Chemotherapy Improves Survival in Older Patients With Acute Myeloid Leukemia

Journal of clinical oncology, 2012-11, Vol.30 (32), p.3924-3931

2012

Link zum Volltext

Verfügbarkeit prüfen

Identification of Patients With Acute Myeloblastic Leukemia Who Benefit From the Addition of Gemtuzumab Ozogamicin: Results of the MRC AML15 Trial

Journal of clinical oncology, 2011-02, Vol.29 (4), p.369-377

2011

Link zum Volltext

Verfügbarkeit prüfen

Physiotherapy for Parkinson's disease: a comparison of techniques

Cochrane database of systematic reviews, 2014-06, Vol.2014 (6), p.CD002815-CD002815

2014

Link zum Volltext

Verfügbarkeit prüfen

Curability of Patients With Acute Myeloid Leukemia Who Did Not Undergo Transplantation in First Remission

Journal of clinical oncology, 2013-04, Vol.31 (10), p.1293-1301

2013

Link zum Volltext

Verfügbarkeit prüfen

Chemotherapy Compared With Biochemotherapy for the Treatment of Metastatic Melanoma: A Meta-Analysis of 18 Trials Involving 2,621 Patients

Journal of clinical oncology, 2007-12, Vol.25 (34), p.5426-5434

2007

Link zum Volltext

Verfügbarkeit prüfen

International randomised controlled trial for the treatment of newly diagnosed EWING sarcoma family of tumours - EURO EWING 2012 Protocol

Trials, 2020-01, Vol.21 (1), p.96-9, Article 96

2020

Link zum Volltext

Verfügbarkeit prüfen

Prospective Minimal Residual Disease Monitoring to Predict Relapse of Acute Promyelocytic Leukemia and to Direct Pre-Emptive Arsenic Trioxide Therapy

Journal of clinical oncology, 2009-08, Vol.27 (22), p.3650-3658

2009

Link zum Volltext

Verfügbarkeit prüfen

Dopamine agonist therapy in early Parkinson's disease

Cochrane database of systematic reviews, 2008-01 (2), p.CD006564

2008

Link zum Volltext

Verfügbarkeit prüfen

Attempts to Optimize Induction and Consolidation Treatment in Acute Myeloid Leukemia: Results of the MRC AML12 Trial

Journal of clinical oncology, 2010-02, Vol.28 (4), p.586-595

2010

Link zum Volltext

Verfügbarkeit prüfen

MPL mutations in myeloproliferative disorders: analysis of the PT-1 cohort

Blood, 2008-07, Vol.112 (1), p.141-149

2008

Link zum Volltext

Verfügbarkeit prüfen

Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis (PEXIVAS): protocol for a randomized controlled trial

Trials, 2013-03, Vol.14 (1), p.73-73

2013

Link zum Volltext

Verfügbarkeit prüfen

Clinical effectiveness and cost-effectiveness of physiotherapy and occupational therapy versus no therapy in mild to moderate Parkinson's disease: a large pragmatic randomised controlled trial (PD REHAB)

Health technology assessment (Winchester, England), 2016-08, Vol.20 (63), p.1-96

2016

Link zum Volltext

Verfügbarkeit prüfen

Cytogenetics of Childhood Acute Myeloid Leukemia: United Kingdom Medical Research Council Treatment Trials AML 10 and 12

Journal of clinical oncology, 2010-06, Vol.28 (16), p.2674-2681

2010

Link zum Volltext

Verfügbarkeit prüfen

Bone marrow pathology in essential thrombocythemia: interobserver reliability and utility for identifying disease subtypes

Blood, 2008-01, Vol.111 (1), p.60-70

2008

Link zum Volltext

Verfügbarkeit prüfen

Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study

The Lancet (British edition), 2005-12, Vol.366 (9501), p.1945-1953

2005

Link zum Volltext

Verfügbarkeit prüfen

Clinical Trials in High-Risk Medulloblastoma: Evolution of the SIOP-Europe HR-MB Trial

Cancers, 2022-01, Vol.14 (2), p.374

2022

Link zum Volltext

Verfügbarkeit prüfen

Comparison of two chemotherapy regimens in Ewing sarcoma (ES): Overall and subgroup results of the Euro Ewing 2012 randomized trial (EE2012)

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.11500-11500

2020

Link zum Volltext

Verfügbarkeit prüfen

Correction: Bailey et al. Clinical Trials in High-Risk Medulloblastoma: Evolution of the SIOP-Europe HR-MB Trial. Cancers 2022, 14 , 374

Cancers, 2024-03, Vol.16 (6), p.1084

2024

Link zum Volltext

Verfügbarkeit prüfen

Warfarin thromboprophylaxis in cancer patients with central venous catheters (WARP): an open-label randomised trial

The Lancet (British edition), 2009-02, Vol.373 (9663), p.567-574

2009

Link zum Volltext

Verfügbarkeit prüfen

Sixteen-week versus standard eight-week prednisolone therapy for childhood nephrotic syndrome: the PREDNOS RCT

Health technology assessment (Winchester, England), 2019-05, Vol.23 (26), p.1-108

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 318

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(306)
Mit Volltextzugriff
(282)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(316)
Japanisch
(36)

Erscheinungsjahr

n.n

Thema

Science & Technology
(180)
Life Sciences & Biomedicine
(172)
Humans
(161)
Female
(84)
Male
(84)
Biological And Medical Sciences
(75)
Medical Sciences
(75)
Treatment Outcome
(62)
Middle Aged
(61)
Oncology
(57)
Adult
(54)
Adolescent
(51)
Hematology
(49)
Aged
(47)
Child
(40)
Hematologic And Hematopoietic Diseases
(38)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(38)
Clinical Trials
(33)
General & Internal Medicine
(33)
Medicine, General & Internal
(33)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(64)
Journal Of Clinical Oncology
(43)
British Journal Of Haematology
(25)
Trials
(13)
Cochrane Database Of Systematic Reviews
(11)
The Lancet
(11)
Bmj
(9)
Current Controlled Trials In Cardiovascular Medicine
(9)
Cochrane Library
(8)
Bmj. British Medical Journal
(6)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Bortezomib for the treatment of multiple myeloma

Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials

Minimal residual disease monitoring by quantitative RT-PCR in core binding factor AML allows risk stratification and predicts relapse: results of the United Kingdom MRC AML-15 trial

Optimization of Chemotherapy for Younger Patients With Acute Myeloid Leukemia: Results of the Medical Research Council AML15 Trial

Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trial

Addition of Gemtuzumab Ozogamicin to Induction Chemotherapy Improves Survival in Older Patients With Acute Myeloid Leukemia

Identification of Patients With Acute Myeloblastic Leukemia Who Benefit From the Addition of Gemtuzumab Ozogamicin: Results of the MRC AML15 Trial

Physiotherapy for Parkinson's disease: a comparison of techniques

Curability of Patients With Acute Myeloid Leukemia Who Did Not Undergo Transplantation in First Remission

Chemotherapy Compared With Biochemotherapy for the Treatment of Metastatic Melanoma: A Meta-Analysis of 18 Trials Involving 2,621 Patients

International randomised controlled trial for the treatment of newly diagnosed EWING sarcoma family of tumours - EURO EWING 2012 Protocol

Prospective Minimal Residual Disease Monitoring to Predict Relapse of Acute Promyelocytic Leukemia and to Direct Pre-Emptive Arsenic Trioxide Therapy

Dopamine agonist therapy in early Parkinson's disease

Attempts to Optimize Induction and Consolidation Treatment in Acute Myeloid Leukemia: Results of the MRC AML12 Trial

MPL mutations in myeloproliferative disorders: analysis of the PT-1 cohort

Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis (PEXIVAS): protocol for a randomized controlled trial

Clinical effectiveness and cost-effectiveness of physiotherapy and occupational therapy versus no therapy in mild to moderate Parkinson's disease: a large pragmatic randomised controlled trial (PD REHAB)

Cytogenetics of Childhood Acute Myeloid Leukemia: United Kingdom Medical Research Council Treatment Trials AML 10 and 12

Bone marrow pathology in essential thrombocythemia: interobserver reliability and utility for identifying disease subtypes

Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study

Clinical Trials in High-Risk Medulloblastoma: Evolution of the SIOP-Europe HR-MB Trial

Comparison of two chemotherapy regimens in Ewing sarcoma (ES): Overall and subgroup results of the Euro Ewing 2012 randomized trial (EE2012)

Correction: Bailey et al. Clinical Trials in High-Risk Medulloblastoma: Evolution of the SIOP-Europe HR-MB Trial. Cancers 2022, 14 , 374

Warfarin thromboprophylaxis in cancer patients with central venous catheters (WARP): an open-label randomised trial

Sixteen-week versus standard eight-week prednisolone therapy for childhood nephrotic syndrome: the PREDNOS RCT

Suchergebnisse filtern